The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer. - Wikidata - wikimedia - TriplyDB

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.

http://www.wikidata.org/entity/Q35858991

about

CXCR4 over-expression and survival in cancer: a system review and meta-analysis A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer.curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome Simultaneous inference of a misclassified outcome and competing risks failure time data Relationships of alpha-SMA-positive fibroblasts and SDF-1-positive tumor cells with neoangiogenesis in nasopharyngeal carcinoma.Inflammatory cell distribution in primary merkel cell carcinoma.Ovulation and extra-ovarian origin of ovarian cancer Differential expression of SDF-1 isoforms in bladder cancer OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets.Imaging CXCL12-CXCR4 signaling in ovarian cancer therapy.An mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids.The prognostic value of CXCR4 in ovarian cancer: a meta-analysis Enhancement of T cell recruitment and infiltration into tumours.Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis.Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells.CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma.Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells A meta-analysis of CXCL12 expression for cancer prognosis.Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.Prediction of anti-angiogenesis escape.Oncogene GAEC1 regulates CAPN10 expression which predicts survival in esophageal squamous cell carcinoma.A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome.Emerging targets in cancer management: role of the CXCL12/CXCR4 axis.miR-9 functions as a tumor inhibitor of cell proliferation in epithelial ovarian cancer through targeting the SDF-1/CXCR4 pathway.Ovarian cancer molecular pathology.Modulating T regulatory cells in cancer: how close are we?Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?CXCR4: a virus's best friend?CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks.Effect of the LPA-mediated CXCL12-CXCR4 axis in the tumor proliferation, migration and invasion of ovarian cancer cell lines.Expression of SDF-1 and CXCR4 transcript variants and CXCR7 in epithelial ovarian cancer.Stromal contributions to the carcinogenic process.Personalized dynamic prediction of death according to tumour progression and high-dimensional genetic factors: Meta-analysis with a joint model.TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy.Harnessing CXCR4 antagonists in stem cell mobilization, HIV infection, ischemic diseases, and oncology.Stromal cell-derived factor 1α (SDF-1α): A marker of disease burden in patients with atrial fibrillation.A joint frailty-copula model between tumour progression and death for meta-analysis.miR-448 negatively regulates ovarian cancer cell growth and metastasis by targeting CXCL12.

P2860

Q28084663-E52B59D1-3BC7-46A3-B9DF-ED7D43F0DB1B Q30569255-0517B20D-E84D-4206-A12A-3759E90C9F4C Q30611147-7E6CFEAF-4A49-4FCA-B432-DE1EFC4D1F13 Q30919342-A325E596-E0E1-4F82-8C0A-B452E0D37356 Q33609069-51EEA1EC-ECB4-45D8-8DD3-6F6B1D4FD945 Q33820294-7CE28D19-8344-4476-868D-219D1B4096AA Q34063581-03C69930-FA6D-4F66-89AF-C544031C024A Q34342390-DFD2B061-7E04-4A93-94D2-AAE475D2FA2F Q34447404-B42CB7E2-C251-4A5C-8854-6EBC2BA4B328 Q34570835-3E81C00A-563B-4535-B018-63EA8A783563 Q35109003-395F8628-FC30-46CD-96C3-273A50CC37B2 Q35127922-617EFC3B-7546-40DF-9C5B-7FF6C4EBE5A5 Q35178939-E59D30B1-7500-47D7-8F24-34D9572C5184 Q35213463-A1FCED60-46BE-4647-ACAD-3B91F9ABD174 Q35550177-9D85ED94-F066-40EF-8617-75EE0C86F658 Q36027105-78B9E656-7FB1-4F8C-8C30-CB59D64156E5 Q36280164-50AC3D4F-DEDF-4133-88B8-F52C5C2D746B Q36293646-4249050B-99AD-4B16-A05C-209E1EE2904B Q36375106-7B10FBD2-46BC-47D5-8584-A9F57701336C Q36378583-5624A89A-7E30-408D-B1AE-59D1211E1E8C Q36413901-E69974AD-F5CD-4927-ADAE-FB718348F4B1 Q36730777-985130DE-30B1-49F8-9798-15B781300283 Q36841319-B9C213DF-F5AE-4BB6-955D-51519D8FEB55 Q36929682-06855A1B-CF1D-46A9-A7BA-CDA3EE8B4700 Q37225329-6E0F2638-39DA-4367-BDAF-EDBE3297C0A3 Q37734627-3B306EC6-A19F-4F95-AB85-4A13DECA2D3A Q38021356-10E44E97-8961-4AE8-8251-433B08FB8C61 Q38097311-4EBE44B5-0CBA-428A-9B08-91FC158C20AE Q38161416-D29BA735-030B-4810-BBBF-6AB2DA23721A Q38209118-E0E4DB65-48D6-4FDE-9A33-C35BBDB3BABC Q38472331-CC2CE059-E0BA-4DC7-A570-604E154F8B14 Q38933315-E5325E89-EE8F-4432-AA06-8F8F82B46D3A Q38933359-602D491F-3429-4100-829C-4CFC36F907F2 Q38992680-49399972-F3D5-4A07-B42D-FDBDB22EB49E Q39019006-B2A37522-41B7-4090-A5F9-DF07A2D19A80 Q39160959-0B304535-01FC-41F3-9D4E-70F3333388E1 Q40109819-8C07781E-A280-4A52-ABB9-AF78BF24D1C5 Q40461623-CC7C9899-1FD2-48A7-954E-DB5EE61E98C3 Q40525129-8C1B2DCB-AA21-47E7-AE5D-14F2FA6810A8 Q40806848-3AF91389-EB76-4982-8D63-E378D73030E6

P2860

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.

http://www.wikidata.org/entity/Q35858991

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.

@ast

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.

@en

type

label

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.

@ast

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.

@en

prefLabel

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.

@ast

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.

@en

P1433

Q35858991-3C0C0C2F-80E3-440B-95EF-260CDF37BE1F

P1476

Q35858991-9F355504-4A8C-47F9-AD66-DF93A9BE1AF2

P2093

Q35858991-0F5965FC-51B3-49C9-9A04-33BBE9061AAF

Q35858991-276E8DE9-329B-4670-8BEE-A3EFCAD63C6D

Q35858991-4CE8AEB4-8F63-4336-ADE6-5B8CAD8159C6

Q35858991-5574C595-03AC-4964-863F-C7C0A44C4399

Q35858991-61C9EEB6-668F-4E5B-836E-50E36F7EB4C2

Q35858991-8A2CF0B0-61E8-49B1-B7B2-6ED8E221F35D

Q35858991-973FDF1D-10F1-45EA-B5F3-0F4DA07B866D

P2860

Q35858991-0E269D5E-9A02-41D7-B100-4A4C86663A26

Q35858991-159CF4F8-6B25-4D54-B445-EE6FEF15C8E0

Q35858991-15D439E1-D344-4581-9C84-62AAD2137BE5

Q35858991-1DD6464E-62D3-424D-AB3E-35113B46853F

Q35858991-1DD860E6-0698-4116-988C-091B804E075D

Q35858991-3367AAB2-3D06-4455-9AA9-D94E8EA6030B

Q35858991-35372614-7E79-4853-9D35-88F686DB7BE9

Q35858991-36EE5AAB-BDA8-43E1-87C1-5956F02392DA

Q35858991-3F70DBF6-B807-4096-9427-B8D188F590A8

Q35858991-4D639819-7BA1-4927-BD01-3C1FBD0A0798

P2888

Q35858991-AF94CD04-CFED-44DF-A222-4C5A790FF790

P304

Q35858991-433A72B4-724C-4D50-9F86-30788E6C293D

P31

Q35858991-A7582AF6-A201-4906-80A7-D789ED1E8BA2

P356

Q35858991-DB9EC13B-05D1-49C9-830F-618919985D47

P407

Q35858991-F1FF80C9-ACF0-416F-B21E-091CB2593952

P433

Q35858991-D35C5A7A-3DB3-4515-85A2-E3FCC2400EAC

P478

Q35858991-E551F8D8-BCFD-45D5-BA39-4FC85070E0DE

P577

Q35858991-475826AE-B53B-4B24-8E19-8C486D206638

P5875

Q35858991-F3E4AC51-8724-4E40-922A-0CAA257D2E56

P6179

Q35858991-9EC830A9-FE72-4B3C-8C6D-3B18BC598BA9

P698

Q35858991-A164DC3E-574F-4E76-B63B-688997028827

P921

Q35858991-953D4809-E332-4E0A-BC04-3406241C2959

P932

Q35858991-210DDFE2-0E7B-448F-9A29-68B5C0F052EF

P356

P1433

British Journal of Cancer

P1476

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.

@en

P2093

A Popple

http://www.w3.org/2001/XMLSchema#string

I Spendlove

http://www.w3.org/2001/XMLSchema#string

I V Scott

http://www.w3.org/2001/XMLSchema#string

J M Ramage

http://www.w3.org/2001/XMLSchema#string

L G Durrant

http://www.w3.org/2001/XMLSchema#string

P Rolland

http://www.w3.org/2001/XMLSchema#string

S Deen

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

Involvement of chemokine receptors in breast cancer metastasis

A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome.

Active movement of T cells away from a chemokine

Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma.

Involvement of autocrine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion.

Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis.

P2888

P304

1306-1313

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2012.49

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221893179

http://www.w3.org/2001/XMLSchema#string

P6179

1026481327

http://www.w3.org/2001/XMLSchema#string

P698

22415233

http://www.w3.org/2001/XMLSchema#string

P921

P932

3314783

http://www.w3.org/2001/XMLSchema#string